2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense

References

• Kobayashi M, Yamamoto M. Molecular mechanisms activating the Nrf2-1 pathway of antioxidant gene regulation. Antioxid Redox Signal 2005;7:385–394.
   PubMed Web of Science ®Google Scholar
• Wangy XJ, Suny Z, Villeneuve NF, Zhang S, Zhao F, Li Y, . Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008;29: 1235–1243.
   Google Scholar
• Nguyen T, Sherratt PJ, Huang HC, Yang CS, Pickett CB. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26S proteasome. J Biol Chem 2003;278:4536–4541.
   PubMed Web of Science ®Google Scholar
• Itoh K, Tong KI, Yamamoto M. Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 2004;36:1208–1213.
   PubMed Web of Science ®Google Scholar
• Wild AC, Moinova HR, Mulcahy RT. Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 1999;274: 33627–33636.
   PubMed Web of Science ®Google Scholar
• Chan JY, Kwong M. Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys Acta 2000; 1517:19–26.
   PubMed Web of Science ®Google Scholar
• Kim YC, Yamaguchi Y, Kondo N, Masutani H, Yodoi JJ. Thioredoxin-dependent redox regulation of the antioxidant responsive element (ARE) in electrophile response. Oncogene 2003;22:1860–1865.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Sato H, Kuriyama-Matsumura K, Sato K, Maebara K, Wang H, . Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression. J Biol Chem 2002;277:44765–44771.
   PubMed Web of Science ®Google Scholar
• Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci USA 1999; 96:12731–12736.
   PubMed Web of Science ®Google Scholar
• Ramos-Gomez M, Kwak MK, Dolan PM, Itoh K, Yamamoto M, Talalay P, Kensler TW. Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in Nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 2001;98:3410–3415.
   PubMed Web of Science ®Google Scholar
• Hayashi A, Suzuki H, Itoh K, Yamamoto M, Sugiyama Y. Transcription factor Nrf2 is required for the constitutive and inducible expression of multidrug resistance-associated protein 1 in mouse embryo fibroblasts. Biochem Biophys Res Commun 2003;310:824–829.
   PubMed Web of Science ®Google Scholar
• Yu X, Kensler T. Nrf2 as a target for cancer chemoprevention. Mutat Res 2005;591:93–102.
   PubMed Web of Science ®Google Scholar
• Shih AY, Imbeault S, Barakauskas V, Erb H, Jiang L, Li P, Murphy TH. Induction of the Nrf2-driven antioxidant response confers neuroprotection during mitochondrial stress in vivo. J Biol Chem 2005;280:22925–22936.
   PubMed Web of Science ®Google Scholar
• Stacy DR, Ely K, Massion PP, Yarbrough WG, Hallahan DE, Sekhar KR, Freeman ML. Increased expression of nuclear factor E2 p45-related factor 2 (NRF2) in head and neck squamous cell carcinomas. Head Neck 2006;28:813–818.
   Google Scholar
• Shibata T, Kokubu A, Gotoh M, Ojima H, Ohta T, Yamamoto M, Hirohashi S. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer. Gastroenterology 2008;135:1358–1368.
   PubMed Web of Science ®Google Scholar
• Shibata T, Ohta T, Tong KI, Kokubu A, Odogawa R, Tsuta K, . Cancer related mutations in Nrf2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci USA 2008;105:13568–13573.
   PubMed Web of Science ®Google Scholar
• Lister A, Nedjadi T, Kitteringham NR, Campbell F, Costello E, Lloyd B, . Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy. Mol Canc 2011;10: 37–49.
   Google Scholar
• Singh A, Bodas M, Wakabayashi N, Bunz F, Biswal S. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal 2010;13:1627–1637.
   PubMed Web of Science ®Google Scholar
• Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Gene Dev 1999;13:76–86.
   PubMed Web of Science ®Google Scholar
• Motohashi H, Shavit JA, Igarashi K, Yamamoto M, Engel JD. The world according to Maf. Nucleic Acids Res 1997;25: 2953–2959.
   PubMed Web of Science ®Google Scholar
• Jain V, Pohlit W. Influence of energy metabolism on the repair of x-ray damage in living cells. I. Effects of respiratory inhibitors and glucose on the liquid-holding reactivation in yeast. Biophysik 1972;8:254–263.
   Google Scholar
• Dwarakanath BS, Jain VK. Energy linked modification of the radiation response in a human cerebral glioma cell line. Int J Radiat Oncol Biol Phy 1989;17:1033–1040.
   PubMed Web of Science ®Google Scholar
• Purohit SC, Pohlit W. Experimental evaluation of the glucose antimetabolite. 2-deoxy-D glucose (2-DG) as a possible adjuvant to radiotherapy of tumours. I. Kinetics of growth and survival of Ehrlich ascites tumour cells (EATC) in vitro and growth of solid tumours after 2-DG and X irradiation. Int J Radiat Oncol Biol Phy 1982;8:495–499.
   PubMed Web of Science ®Google Scholar
• Mohanti BK, Rath GK, Anantha N, Kannan V, Das BS, Chandramouli AR, . Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phy 1996;35:103–111.
   PubMed Web of Science ®Google Scholar
• Jain V. Modifications of radiation responses by 2-deoxy-D-glucose in normal and cancer cells. Ind J Nucl Med 1996;11:8–17.
   Google Scholar
• Dwarakanath BS, Zolzer F, Chandana S, Bauch T, Adhikari JS, Muller W, . Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumour cell lines. Int J Radiat Oncol Biol Phy 2001;50:1051–1061.
   PubMed Web of Science ®Google Scholar
• Varshney R, Dwarakanath BS, Jain V. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells. Int J Radiat Biol 2005;81:397–408.
   PubMed Web of Science ®Google Scholar
• Varshney R, Gupta S, Dwarakanath BS. Radiosensitization of murine Ehrlich ascites tumor by a combination of 2-deoxy-Dglucose and 6-aminonicotinamide. Technol Cancer Res 2004;3:659–663.
   PubMed Web of Science ®Google Scholar
• Sharma PK, Bhardwaj R, Dwarakanath BS, Varshney R. Metabolic oxidative stress induced by a combination of 2-DG and 6-AN enhances radiation damage selectively in malignant cells via non-coordinated expression of antioxidant enzymes. Cancer Lett 2010;295:154–166.
   PubMed Web of Science ®Google Scholar
• Bhardwaj R, Sharma PK, Jadon SPS, Varshney R. A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces oxidative stress mediated selective radiosensitization of malignant cells via mitochondrial dysfunction. Tumor Biol 2011; 32:951–964.
   Google Scholar
• Bhardwaj R, Sharma PK, Jadon SPS, Varshney R. A combination of 2-deoxy-D-glucose and 6-aminonicotinamide induces cell cycle arrest and apoptosis selectively in irradiated human malignant cells. Tumor Biol 2012;33:1021–1030.
   Google Scholar
• Dieterich S, Bieligk U, Beulich K, Hasenfuss G, Prestle J. Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart. Circulation 2000;101;33–39.
   PubMed Web of Science ®Google Scholar
• Corrales RM, Galarreta D, Herreras J, Calonge M, Chaves F. Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects. Can J Ophthalmol 2011;46: 35–39.
   PubMed Web of Science ®Google Scholar
• Oguri T, Fujiwaral Y, Isobel T, Katoh O, Watanabe H, Yamakido M. Expression of y-glutamylcysteine synthetase (y-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs. Br J Canc 1998;77:1089–1096.
   PubMed Web of Science ®Google Scholar
• Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S, . Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J 2006; 20:E2166–E2176.
   Google Scholar
• Wang R, An J, Ji F, Jiao H, Sun H, Zhou D. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues. Biochem Biophys Res Commun 2008;373:151–154.
   PubMed Web of Science ®Google Scholar
• Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42–59.
   PubMed Web of Science ®Google Scholar
• Harvey CJ, Thimmulappa RK, Singh A, Blake DJ, Ling G, Wakabayashi N, . Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress. Free Radic Biol Med 2009;46:443–453.
   PubMed Web of Science ®Google Scholar
• Lee YJ, Galoforo SS, Berns CM, Chen JC, Davis BH, Sim JE, . Glucose deprivation-induced cytotoxicity and alterations in mitogen-activated protein kinase activation are mediated by oxidative stress in multidrug-resistant human breast carcinoma cells. J Biol Chem 1998;273:5294–5299.
   PubMed Web of Science ®Google Scholar
• Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, . 2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 2004;64:31–34.
   PubMed Web of Science ®Google Scholar
• Cho HY, Reddy SP, Yamamoto M, Kleeberger SR. The transcription factor Nrf2 protects against pulmonary fibrosis. FASEB J 2004;18:1258–1260.
   PubMed Web of Science ®Google Scholar
• Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, . RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res 2008;68:7975–7984.
   PubMed Web of Science ®Google Scholar
• Zhang P, Singh A, Yegnasubramanian S, Esopi D, Kombairaju P, Bodas M, . Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth. Mol Cancer Ther 2010;9:336–346.
   PubMed Web of Science ®Google Scholar
• Homma S, Ishii Y, Morishima Y, Yamadori T, Matsuno Y, Haraguchi N, . Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer. Clin Cancer Res 2009;15:3423–3432.
   PubMed Web of Science ®Google Scholar
• Hong YB, Kang HJ, Kwon SY, Kim HJ, Kwon KY, Cho CH, . Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells. Pancreas 2010;39:463–472.
   PubMed Web of Science ®Google Scholar
• Ren D, Villeneuve NF, Jiang T, Wu T, Lau A, Toppin HA, Zhang DD. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism. Proc Natl Acad Sci USA 2011;108:1433–1438.
   PubMed Web of Science ®Google Scholar
• Kobayashi A, Kang MI, Okawa H, Ohtsuji M, Zenke Y, Chiba T, . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004;24:7130–7139.
   PubMed Web of Science ®Google Scholar
• Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, . Dysfunctional KEAP1–NRF2 interaction in non-small-cell lung cancer. PLoS Med 2006;3:e420.
   PubMed Web of Science ®Google Scholar
• Nioi P, Nguyen T. A mutation of Keap1 found in breast cancer impairs its ability to repress Nrf2 activity. Biochem Biophys Res Commun 2007;362:816–821.
   PubMed Web of Science ®Google Scholar
• Ohta T, Iijima K, Miyamoto M, Nakahara I, Tanaka H, Ohtsuji M, . Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth. Cancer Res 2008;68:1303–1309.
   PubMed Web of Science ®Google Scholar
• McMahon M, Thomas N, Itoh K, Yamamoto M, Hayes JD. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a “Tethering” mechanism a two-site interaction model for the Nrf2-Keap1 complex. J Biol Chem 2006;281:24756–24768.
   PubMed Web of Science ®Google Scholar
• Ogura T, Tong KI, Mio K, Maruyama Y, Kurokawa H, Sato C, Yamamoto M. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc Natl Acad Sci USA 2010;107: 2842–2847.
   PubMed Web of Science ®Google Scholar
• Tong KI, Katoh Y, Kusunoki H, Itoh K, Tanaka T, Yamamoto T. Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model. Mol Cell Biol 2006;26:2887–2900.
   PubMed Web of Science ®Google Scholar
• McDonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, Lagadec C, . Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res 2010;70:8886–8895.
   PubMed Web of Science ®Google Scholar